Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cryptococcosis | 2 | 2022 | 31 | 1.460 |
Why?
|
| Invasive Pulmonary Aspergillosis | 2 | 2021 | 7 | 1.330 |
Why?
|
| Bacillus | 1 | 2022 | 17 | 0.730 |
Why?
|
| Noise | 1 | 2023 | 71 | 0.730 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2022 | 51 | 0.710 |
Why?
|
| Aspergillus fumigatus | 1 | 2020 | 25 | 0.650 |
Why?
|
| Bacteremia | 1 | 2022 | 221 | 0.600 |
Why?
|
| Posterior Leukoencephalopathy Syndrome | 1 | 2019 | 10 | 0.600 |
Why?
|
| Scleritis | 1 | 2019 | 28 | 0.590 |
Why?
|
| Endophthalmitis | 1 | 2019 | 45 | 0.590 |
Why?
|
| Transfusion Reaction | 1 | 2019 | 63 | 0.580 |
Why?
|
| Endocarditis, Bacterial | 1 | 2019 | 44 | 0.580 |
Why?
|
| Cause of Death | 1 | 2021 | 471 | 0.570 |
Why?
|
| Intensive Care Units | 2 | 2021 | 916 | 0.540 |
Why?
|
| Erythrocyte Transfusion | 1 | 2019 | 231 | 0.510 |
Why?
|
| Streptococcal Infections | 1 | 2019 | 168 | 0.500 |
Why?
|
| Hypertension, Malignant | 1 | 2016 | 3 | 0.500 |
Why?
|
| Purpura, Thrombotic Thrombocytopenic | 1 | 2016 | 14 | 0.490 |
Why?
|
| Thrombotic Microangiopathies | 1 | 2016 | 19 | 0.490 |
Why?
|
| Pelvic Inflammatory Disease | 1 | 2016 | 12 | 0.490 |
Why?
|
| Ceftriaxone | 1 | 2016 | 21 | 0.490 |
Why?
|
| Chlamydia trachomatis | 1 | 2016 | 49 | 0.480 |
Why?
|
| Hepatitis | 1 | 2016 | 43 | 0.480 |
Why?
|
| Doxycycline | 1 | 2016 | 62 | 0.480 |
Why?
|
| Peritonitis | 1 | 2016 | 84 | 0.460 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 384 | 0.450 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 378 | 0.450 |
Why?
|
| Chlamydia Infections | 1 | 2016 | 81 | 0.450 |
Why?
|
| Abdominal Pain | 1 | 2016 | 146 | 0.440 |
Why?
|
| Caregivers | 1 | 2023 | 1049 | 0.410 |
Why?
|
| Anti-Bacterial Agents | 3 | 2022 | 1907 | 0.380 |
Why?
|
| Onions | 1 | 2010 | 2 | 0.330 |
Why?
|
| Genes, Insect | 1 | 2010 | 22 | 0.330 |
Why?
|
| Arthropod Antennae | 1 | 2010 | 4 | 0.330 |
Why?
|
| Expressed Sequence Tags | 1 | 2010 | 43 | 0.330 |
Why?
|
| Insect Proteins | 1 | 2010 | 40 | 0.320 |
Why?
|
| Diptera | 1 | 2010 | 31 | 0.320 |
Why?
|
| Receptors, Odorant | 1 | 2010 | 32 | 0.320 |
Why?
|
| Medical Staff | 1 | 2023 | 17 | 0.190 |
Why?
|
| Mucormycosis | 1 | 2022 | 19 | 0.180 |
Why?
|
| Nose Diseases | 1 | 2022 | 17 | 0.180 |
Why?
|
| Blood Culture | 1 | 2022 | 25 | 0.180 |
Why?
|
| Orbital Diseases | 1 | 2022 | 35 | 0.180 |
Why?
|
| Gram-Negative Bacteria | 1 | 2022 | 81 | 0.170 |
Why?
|
| Humans | 13 | 2023 | 144759 | 0.170 |
Why?
|
| New York City | 1 | 2020 | 89 | 0.160 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2023 | 285 | 0.160 |
Why?
|
| Mobile Applications | 1 | 2023 | 196 | 0.160 |
Why?
|
| Propensity Score | 1 | 2022 | 367 | 0.160 |
Why?
|
| Perception | 1 | 2023 | 377 | 0.150 |
Why?
|
| Fatal Outcome | 1 | 2020 | 307 | 0.150 |
Why?
|
| Ceftazidime | 1 | 2019 | 7 | 0.150 |
Why?
|
| Intravitreal Injections | 1 | 2019 | 71 | 0.150 |
Why?
|
| Streptococcus pyogenes | 1 | 2019 | 41 | 0.150 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2019 | 72 | 0.140 |
Why?
|
| Mitral Valve | 1 | 2019 | 96 | 0.140 |
Why?
|
| Vancomycin | 1 | 2019 | 93 | 0.140 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2019 | 62 | 0.140 |
Why?
|
| Aged, 80 and over | 2 | 2021 | 8265 | 0.140 |
Why?
|
| Vaccines | 1 | 2023 | 389 | 0.140 |
Why?
|
| Merozoite Surface Protein 1 | 1 | 2017 | 4 | 0.130 |
Why?
|
| Plasmodium yoelii | 1 | 2017 | 7 | 0.130 |
Why?
|
| Antigens, Protozoan | 1 | 2017 | 32 | 0.130 |
Why?
|
| Protozoan Proteins | 1 | 2017 | 93 | 0.120 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2019 | 3863 | 0.120 |
Why?
|
| Malaria | 1 | 2017 | 73 | 0.120 |
Why?
|
| Contact Tracing | 1 | 2016 | 26 | 0.120 |
Why?
|
| Sex Work | 1 | 2016 | 22 | 0.120 |
Why?
|
| Adult | 4 | 2022 | 40449 | 0.120 |
Why?
|
| Directive Counseling | 1 | 2016 | 44 | 0.120 |
Why?
|
| Echocardiography | 1 | 2019 | 652 | 0.120 |
Why?
|
| Length of Stay | 1 | 2022 | 1337 | 0.120 |
Why?
|
| Respiration, Artificial | 1 | 2020 | 708 | 0.110 |
Why?
|
| Receptors, Cell Surface | 1 | 2017 | 377 | 0.110 |
Why?
|
| Incidence | 1 | 2021 | 2879 | 0.100 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 1047 | 0.100 |
Why?
|
| Diabetes Mellitus | 1 | 2022 | 1098 | 0.100 |
Why?
|
| Retrospective Studies | 2 | 2022 | 17066 | 0.100 |
Why?
|
| Middle Aged | 3 | 2021 | 35875 | 0.090 |
Why?
|
| Follow-Up Studies | 1 | 2022 | 5408 | 0.090 |
Why?
|
| Antihypertensive Agents | 1 | 2016 | 510 | 0.090 |
Why?
|
| Renal Dialysis | 1 | 2016 | 462 | 0.090 |
Why?
|
| Male | 4 | 2021 | 72315 | 0.090 |
Why?
|
| Pandemics | 1 | 2020 | 1694 | 0.090 |
Why?
|
| Cohort Studies | 1 | 2022 | 5960 | 0.090 |
Why?
|
| Aged | 2 | 2021 | 25913 | 0.080 |
Why?
|
| Drosophila | 1 | 2010 | 166 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 983 | 0.070 |
Why?
|
| Brain | 1 | 2019 | 2933 | 0.060 |
Why?
|
| Female | 3 | 2021 | 78271 | 0.060 |
Why?
|
| Risk Factors | 1 | 2020 | 10779 | 0.060 |
Why?
|
| Phylogeny | 1 | 2010 | 1016 | 0.060 |
Why?
|
| Molecular Sequence Data | 1 | 2010 | 2930 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2016 | 2730 | 0.060 |
Why?
|
| Japan | 1 | 2023 | 143 | 0.050 |
Why?
|
| Child | 1 | 2023 | 22633 | 0.050 |
Why?
|
| Intention | 1 | 2023 | 183 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2010 | 2608 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2016 | 11679 | 0.040 |
Why?
|
| Glucocorticoids | 1 | 2022 | 535 | 0.030 |
Why?
|
| Immunity | 1 | 2017 | 139 | 0.030 |
Why?
|
| Pain | 1 | 2022 | 779 | 0.030 |
Why?
|
| Host-Parasite Interactions | 1 | 2017 | 112 | 0.030 |
Why?
|
| Virulence | 1 | 2017 | 278 | 0.030 |
Why?
|
| Erythrocytes | 1 | 2017 | 757 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2017 | 2145 | 0.020 |
Why?
|
| Animals | 1 | 2010 | 38058 | 0.020 |
Why?
|